Simulations Plus, Inc.
NASDAQ:SLPMedical - Healthcare Information Services
+$0.02 today
- Market cap
- $374.16M
- Beta
- 1.32
- P/E (TTM)
- -5.9
- EPS (TTM)
- -$3.12
Volume 0.00M
Average 0.35M
SLP Gross Profit
Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.
Simulations Plus, Inc.NASDAQ: SLP
Gross Profit · Q2 FY2026 · quarter ended Feb 2026
Gross profit growth accelerates
Q2 FY2026 gross profit of $16.14M rose 23.0% year over year, ahead of the +14.9% change in trailing-twelve-month gross profit. Sequentially, it rose 48.2% from the prior quarter. Over 3 fiscal years it compounded at +2.4% a year.
Context
- Gross profit amounted to 58.4% of revenue in FY2025, down 3.3 pp from a year earlier.
- Gross profit increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +23.0% holds above the trailing-twelve-month pace of +14.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Profit history
USD · from the income statement
- Latest · FY2025
- 46.22M USD
- Year-over-year change
- +7.1%
- 4-year CAGR
- +6.5%
| Period | Period end | Gross Profit | YoY change |
|---|---|---|---|
| FY2025 | 2025-08-31 | 46.22M | +7.1% |
| FY2024 | 2024-08-31 | 43.15M | -10.0% |
| FY2023 | 2023-08-31 | 47.95M | +11.3% |
| FY2022 | 2022-08-31 | 43.08M | +20.1% |
| FY2021 | 2021-08-31 | 35.87M | — |
Gross Profit vs competitors
How SLP compares with its peers on the latest reported figures
- Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +14.9% is the 4th highest of 11, against a peer median of -25.5%.
- Gross profit amounts to 62.0% of revenue for SLP, versus a peer median of 72.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $172.84M USD | -9.4% | +0.6% | 72.5% | |
| LTM Mar 2026 | $77.43M USD | -7.4% | -6.4% | 55.9% | |
| LTM Mar 2026 | $74.12M USD | +22.5% | +21.1% | 69.0% | |
| LTM Mar 2026 | $55.76M USD | +43.8% | +80.8% | 81.9% | |
| LTM Mar 2026 | $54.62M USD | +19.4% | +15.2% | 67.3% | |
| LTM Feb 2026 | $49.91M USD | +14.9% | +2.4% | 62.0% | |
| LTM Mar 2026 | CHF 3.7M CHF | -86.9% | -3.2% | 100.0% | |
| LTM Mar 2026 | $2.81M USD | -41.7% | — | 73.2% | |
| LTM Mar 2026 | -$284K USD | -67.1% | — | — | |
| LTM Mar 2026 | -$14.74M USD | -798.8% | — | 376.0% | |
| LTM Mar 2026 | -$159.48M USD | -716.8% | — | 2.7% | |
| Peer median (excluding SLP) | — | -25.5% | +7.9% | 72.5% | |
Competitors are the stored peer set for SLP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Aug 2021 | FY2022 Aug 2022 | FY2023 Aug 2023 | FY2024 Aug 2024 | FY2025 Aug 2025 |
|---|---|---|---|---|---|
| Revenue | 46.47M | 53.91M | 59.58M | 70.01M | 79.18M |
| Cost of Revenue | 10.6M | 10.82M | 11.63M | 26.86M | 32.96M |
| Gross Profit | 35.87M | 43.08M | 47.95M | 43.15M | 46.22M |
| Gross Margin | 77.2% | 79.9% | 80.5% | 61.6% | 58.4% |
| Research & Development | 4.05M | 3.21M | 4.5M | 5.75M | 6.88M |
| Selling, General & Admin | 20.57M | 24.97M | 34.72M | 31.27M | 32.85M |
| Operating Expenses | 24.61M | 28.17M | 39.22M | 37.02M | 116.95M |
| Depreciation & Amortization | 3.59M | 3.57M | 3.84M | 5.67M | 8.21M |
| EBITDA | 14.7M | 18.69M | 13.07M | 18.08M | 14.7M |
| EBITDA Margin | 31.6% | 34.7% | 21.9% | 25.8% | 18.6% |
| Operating Income | 11.25M | 14.91M | 8.73M | 6.13M | (70.73M) |
| Operating Margin | 24.2% | 27.7% | 14.6% | 8.8% | -89.3% |
| Interest Income | 201K | 717K | 4.13M | 4.38M | 722K |
| Interest Expense | 22K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (168K) | 204K | 2.97M | 6.28M | 1.35M |
| Income Before Tax | 11.09M | 15.12M | 11.7M | 12.41M | (69.38M) |
| Pre-Tax Margin | 23.9% | 28.0% | 19.6% | 17.7% | -87.6% |
| Income Tax Expense | 1.3M | 2.63M | 1.73M | 2.46M | (4.66M) |
| Net Income | 9.78M | 12.48M | 9.96M | 9.95M | (64.72M) |
| Net Margin | 21.1% | 23.2% | 16.7% | 14.2% | -81.7% |
| EPS (Basic) | 0.49 | 0.62 | 0.50 | 0.50 | (3.22) |
| EPS (Diluted) | 0.47 | 0.60 | 0.49 | 0.49 | (3.22) |
| Weighted Avg Shares | 20.05M | 20.2M | 20.08M | 19.99M | 20.1M |
| Weighted Avg Shares (Diluted) | 20.74M | 20.75M | 20.47M | 20.3M | 20.1M |
Simulations Plus, Inc.
NASDAQ:SLP
Intrinsic Alpha fair value
Locked
Current Price
$18.50
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.